Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Aug;55(8):513–519. doi: 10.1136/ard.55.8.513

Neutral endopeptidase (EC 3.4.24.11) in labial salivary glands in healthy controls and in patients with Sjögren's syndrome.

Y T Konttinen 1, J Törnwall 1, P Kemppinen 1, H Uusitalo 1, T Sorsa 1, M Hukkanen 1, J M Polak 1
PMCID: PMC1010230  PMID: 8774178

Abstract

OBJECTIVE: Neuropeptides from nerve fibres can cause neurogenic inflammation. The potency of these peptides in vitro has led to the hypothesis that enzyme degradative systems are operative in vivo to limit their action. To consider this question neutral endopeptidase (NEP) in labial salivary glands in patients with Sjögren's syndrome was studied. METHODS: Synthesis of NEP mRNA in situ in labial salivary glands was studied using the reverse transcriptase polymerase chain reaction (RT-PCR). Immunohistochemical staining was used to localise the NEP enzyme protein and its neuropeptide substrates and fluorophotometry to measure the corresponding enzyme activities in saliva. RESULTS: NEP was found in nerve fibres and in perivascular, periductal, and periacinar axon terminal varicosities. Double labelling of PGP 9.5 and NEP confirmed this neuronal localisation of NEP. Although some fibroblast-like cells and occasional intravascular neutrophils were NEP positive, NEP mRNA was not found in labial salivary glands. Patients with Sjögren's syndrome and healthy controls did not have nerves containing NEP or neuropeptides (vasoactive intestinal peptide, substance P, or calcitonin gene related peptide (CGRP)) in lymphocyte foci. Salivary NEP activity was not decreased in patients compared with controls. CONCLUSION: NEP in labial salivary glands is almost totally of neuronal origin and plays a part in proteolytic modulation of neuropeptides in salivary glands and saliva. These regulatory interactions seem to be altered in focal lymphocyte accumulations in Sjögren's syndrome.

Full text

PDF
513

Images in this article

515Image
on p.515
516Image
on p.516
516Image
on p.516
516Image
on p.516

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Back S. A., Gorenstein C. Differential response of neutral endopeptidase 24.11 ("enkephalinase"), and cholinergic and opioidergic markers to hypoglossal axotomy. J Comp Neurol. 1994 Feb 8;340(2):149–160. doi: 10.1002/cne.903400202. [DOI] [PubMed] [Google Scholar]
  2. Bobyock E., Barbieri E. J., Chernick W. S. Effects of substance P and substance P antagonists on rat salivary secretion. J Dent Res. 1986 Dec;65(12):1427–1431. doi: 10.1177/00220345860650121001. [DOI] [PubMed] [Google Scholar]
  3. Bowes M. A., Kenny A. J. Endopeptidase-24.11 in pig lymph nodes. Purification and immunocytochemical localization in reticular cells. Biochem J. 1986 Jun 15;236(3):801–810. doi: 10.1042/bj2360801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bunnett N. W., Turner A. J., Hryszko J., Kobayashi R., Walsh J. H. Isolation of endopeptidase-24.11 (EC 3.4.24.11, "enkephalinase") from the pig stomach. Hydrolysis of substance P, gastrin-releasing peptide 10, [Leu5] enkephalin, and [Met5] enkephalin. Gastroenterology. 1988 Oct;95(4):952–957. doi: 10.1016/0016-5085(88)90168-0. [DOI] [PubMed] [Google Scholar]
  5. Connelly J. C., Skidgel R. A., Schulz W. W., Johnson A. R., Erdös E. G. Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8737–8741. doi: 10.1073/pnas.82.24.8737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. D'Adamio L., Shipp M. A., Masteller E. L., Reinherz E. L. Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7103–7107. doi: 10.1073/pnas.86.18.7103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Daniels T. E. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum. 1984 Feb;27(2):147–156. doi: 10.1002/art.1780270205. [DOI] [PubMed] [Google Scholar]
  8. Devault A., Lazure C., Nault C., Le Moual H., Seidah N. G., Chrétien M., Kahn P., Powell J., Mallet J., Beaumont A. Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA. EMBO J. 1987 May;6(5):1317–1322. doi: 10.1002/j.1460-2075.1987.tb02370.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ekström J. Choline acetyltransferase activity in rat salivary glands after cellulose rich diet or treatment with an atropine-like drug. Q J Exp Physiol Cogn Med Sci. 1974 Jul;59(3):191–199. doi: 10.1113/expphysiol.1974.sp002261. [DOI] [PubMed] [Google Scholar]
  10. Ekström J., Månsson B., Tobin G., Garrett J. R., Thulin A. Atropine-resistant secretion of parotid saliva on stimulation of the auriculo-temporal nerve. Acta Physiol Scand. 1983 Dec;119(4):445–449. doi: 10.1111/j.1748-1716.1983.tb07360.x. [DOI] [PubMed] [Google Scholar]
  11. Ekström J., Olgart L. Complementary action of substance P and vasoactive intestinal peptide on the rat parotid secretion. Acta Physiol Scand. 1986 Jan;126(1):25–31. doi: 10.1111/j.1748-1716.1986.tb07784.x. [DOI] [PubMed] [Google Scholar]
  12. Emmelin N. Nerve interactions in salivary glands. J Dent Res. 1987 Feb;66(2):509–517. doi: 10.1177/00220345870660022101. [DOI] [PubMed] [Google Scholar]
  13. Fox R. I., Howell F. V., Bone R. C., Michelson P. Primary Sjogren syndrome: clinical and immunopathologic features. Semin Arthritis Rheum. 1984 Nov;14(2):77–105. doi: 10.1016/0049-0172(84)90001-5. [DOI] [PubMed] [Google Scholar]
  14. Fulcher I. S., Chaplin M. F., Kenny A. J. Endopeptidase-24.11 purified from pig intestine is differently glycosylated from that in kidney. Biochem J. 1983 Nov 1;215(2):317–323. doi: 10.1042/bj2150317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gafford J. T., Skidgel R. A., Erdös E. G., Hersh L. B. Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides. Biochemistry. 1983 Jun 21;22(13):3265–3271. doi: 10.1021/bi00282a035. [DOI] [PubMed] [Google Scholar]
  16. Gallacher D. V. Substance P is a functional neurotransmitter in the rat parotid gland. J Physiol. 1983 Sep;342:483–498. doi: 10.1113/jphysiol.1983.sp014864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Garrett J. R. The proper role of nerves in salivary secretion: a review. J Dent Res. 1987 Feb;66(2):387–397. doi: 10.1177/00220345870660020201. [DOI] [PubMed] [Google Scholar]
  18. Goetzl E. J., Sreedharan S. P., Turck C. W., Bridenbaugh R., Malfroy B. Preferential cleavage of amino- and carboxyl-terminal oligopeptides from vasoactive intestinal polypeptide by human recombinant enkephalinase (neutral endopeptidase, EC 3.4.24.11). Biochem Biophys Res Commun. 1989 Feb 15;158(3):850–854. doi: 10.1016/0006-291x(89)92800-3. [DOI] [PubMed] [Google Scholar]
  19. Greenspan J. S., Daniels T. E., Talal N., Sylvester R. A. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol. 1974 Feb;37(2):217–229. doi: 10.1016/0030-4220(74)90417-4. [DOI] [PubMed] [Google Scholar]
  20. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  21. Kerr M. A., Kenny A. J. The molecular weight and properties of a neutral metallo-endopeptidase from rabbit kidney brush border. Biochem J. 1974 Mar;137(3):489–495. doi: 10.1042/bj1370489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kerr M. A., Kenny A. J. The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem J. 1974 Mar;137(3):477–488. doi: 10.1042/bj1370477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Konttinen Y. T., Hukkanen M., Kemppinen P., Segerberg M., Sorsa T., Malmström M., Rose S., Itescu S., Polak J. M. Peptide-containing nerves in labial salivary glands in Sjögren's syndrome. Arthritis Rheum. 1992 Jul;35(7):815–820. doi: 10.1002/art.1780350717. [DOI] [PubMed] [Google Scholar]
  24. Lotz M., Carson D. A., Vaughan J. H. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science. 1987 Feb 20;235(4791):893–895. doi: 10.1126/science.2433770. [DOI] [PubMed] [Google Scholar]
  25. Lotz M., Vaughan J. H., Carson D. A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 1988 Sep 2;241(4870):1218–1221. doi: 10.1126/science.2457950. [DOI] [PubMed] [Google Scholar]
  26. Malfroy B., Kuang W. J., Seeburg P. H., Mason A. J., Schofield P. R. Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett. 1988 Feb 29;229(1):206–210. doi: 10.1016/0014-5793(88)80828-7. [DOI] [PubMed] [Google Scholar]
  27. Malfroy B., Schofield P. R., Kuang W. J., Seeburg P. H., Mason A. J., Henzel W. J. Molecular cloning and amino acid sequence of rat enkephalinase. Biochem Biophys Res Commun. 1987 Apr 14;144(1):59–66. doi: 10.1016/s0006-291x(87)80475-8. [DOI] [PubMed] [Google Scholar]
  28. Manthorpe R., Oxholm P., Prause J. U., Schiødt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol Suppl. 1986;61:19–21. [PubMed] [Google Scholar]
  29. Moutsopoulos H. M., Chused T. M., Mann D. L., Klippel J. H., Fauci A. S., Frank M. M., Lawley T. J., Hamburger M. I. Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med. 1980 Feb;92(2 Pt 1):212–226. doi: 10.7326/0003-4819-92-2-212. [DOI] [PubMed] [Google Scholar]
  30. Pollard H., Bouthenet M. L., Moreau J., Souil E., Verroust P., Ronco P., Schwartz J. C. Detailed immunoautoradiographic mapping of enkephalinase (EC 3.4.24.11) in rat central nervous system: comparison with enkephalins and substance P. Neuroscience. 1989;30(2):339–376. doi: 10.1016/0306-4522(89)90258-3. [DOI] [PubMed] [Google Scholar]
  31. Schneyer C. A., Hall H. D. Function of rat parotid gland after sympathectomy and total postganglionectomy. Am J Physiol. 1966 Oct;211(4):943–949. doi: 10.1152/ajplegacy.1966.211.4.943. [DOI] [PubMed] [Google Scholar]
  32. Scully C. Sjögren's syndrome: clinical and laboratory features, immunopathogenesis, and management. Oral Surg Oral Med Oral Pathol. 1986 Nov;62(5):510–523. doi: 10.1016/0030-4220(86)90313-0. [DOI] [PubMed] [Google Scholar]
  33. Shipp M. A., Richardson N. E., Sayre P. H., Brown N. R., Masteller E. L., Clayton L. K., Ritz J., Reinherz E. L. Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4819–4823. doi: 10.1073/pnas.85.13.4819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Skidgel R. A., Engelbrecht S., Johnson A. R., Erdös E. G. Hydrolysis of substance p and neurotensin by converting enzyme and neutral endopeptidase. Peptides. 1984 Jul-Aug;5(4):769–776. doi: 10.1016/0196-9781(84)90020-2. [DOI] [PubMed] [Google Scholar]
  35. Spillantini M. G., Geppetti P., Fanciullacci M., Michelacci S., Lecomte J. M., Sicuteri F. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF. Eur J Pharmacol. 1986 Jun 5;125(1):147–150. doi: 10.1016/0014-2999(86)90094-4. [DOI] [PubMed] [Google Scholar]
  36. Stanisz A. M., Befus D., Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol. 1986 Jan;136(1):152–156. [PubMed] [Google Scholar]
  37. Törnwall J., Konttinen Y. T., Hietanen J., Sorsa T., Hukkanen M., Uusitalo H. VIP in salivary glands in Sjögren's syndrome. Br J Rheumatol. 1995 Sep;34(9):891–893. doi: 10.1093/rheumatology/34.9.891. [DOI] [PubMed] [Google Scholar]
  38. Törnwall J., Uusitalo H., Hukkanen M., Sorsa T., Konttinen Y. T. Distribution of vasoactive intestinal peptide (VIP) and its binding sites in labial salivary glands in Sjögren's syndrome and in normal controls. Clin Exp Rheumatol. 1994 May-Jun;12(3):287–292. [PubMed] [Google Scholar]
  39. Wilkinson K. D., Lee K. M., Deshpande S., Duerksen-Hughes P., Boss J. M., Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science. 1989 Nov 3;246(4930):670–673. doi: 10.1126/science.2530630. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES